Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Susceptibility to Creutzfeldt-Jakob disease after human growth hormone treatment in France.

Peckeu L, Brandel JP, Welaratne A, Costagliola D, Haïk S.

Neurology. 2018 Aug 21;91(8):e724-e731. doi: 10.1212/WNL.0000000000006028. Epub 2018 Jul 25.

PMID:
30045957
2.

Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases.

Hirsch TZ, Martin-Lannerée S, Reine F, Hernandez-Rapp J, Herzog L, Dron M, Privat N, Passet B, Halliez S, Villa-Diaz A, Lacroux C, Klein V, Haïk S, Andréoletti O, Torres JM, Vilotte JL, Béringue V, Mouillet-Richard S.

Mol Neurobiol. 2018 Jul 11. doi: 10.1007/s12035-018-1193-7. [Epub ahead of print]

PMID:
29998397
3.

Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative Diseases.

Vanni S, Zattoni M, Moda F, Giaccone G, Tagliavini F, Haïk S, Deslys JP, Zanusso G, Ironside JW, Carmona M, Ferrer I, Kovacs GG, Legname G.

Front Neurosci. 2018 Jan 22;12:8. doi: 10.3389/fnins.2018.00008. eCollection 2018.

4.

Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.

Cali I, Cohen ML, Haik S, Parchi P, Giaccone G, Collins SJ, Kofskey D, Wang H, McLean CA, Brandel JP, Privat N, Sazdovitch V, Duyckaerts C, Kitamoto T, Belay ED, Maddox RA, Tagliavini F, Pocchiari M, Leschek E, Appleby BS, Safar JG, Schonberger LB, Gambetti P.

Acta Neuropathol Commun. 2018 Jan 8;6(1):5. doi: 10.1186/s40478-017-0503-z.

5.

Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology.

Duyckaerts C, Sazdovitch V, Ando K, Seilhean D, Privat N, Yilmaz Z, Peckeu L, Amar E, Comoy E, Maceski A, Lehmann S, Brion JP, Brandel JP, Haïk S.

Acta Neuropathol. 2018 Feb;135(2):201-212. doi: 10.1007/s00401-017-1791-x. Epub 2017 Nov 22.

PMID:
29209767
6.

Differential overexpression of SERPINA3 in human prion diseases.

Vanni S, Moda F, Zattoni M, Bistaffa E, De Cecco E, Rossi M, Giaccone G, Tagliavini F, Haïk S, Deslys JP, Zanusso G, Ironside JW, Ferrer I, Kovacs GG, Legname G.

Sci Rep. 2017 Nov 15;7(1):15637. doi: 10.1038/s41598-017-15778-8.

7.

Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque.

Comoy EE, Mikol J, Jaffré N, Lebon V, Levavasseur E, Streichenberger N, Sumian C, Perret-Liaudet A, Eloit M, Andreoletti O, Haïk S, Hantraye P, Deslys JP.

Nat Commun. 2017 Nov 2;8(1):1268. doi: 10.1038/s41467-017-01347-0.

8.

Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009.

Peckeu L, Delasnerie-Lauprètre N, Brandel JP, Salomon D, Sazdovitch V, Laplanche JL, Duyckaerts C, Seilhean D, Haïk S, Hauw JJ.

Euro Surveill. 2017 Oct;22(41). doi: 10.2807/1560-7917.ES.2017.22.41.16-00715.

9.

Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.

Privat N, Levavasseur E, Yildirim S, Hannaoui S, Brandel JP, Laplanche JL, Béringue V, Seilhean D, Haïk S.

J Biol Chem. 2017 Oct 6;292(40):16688-16696. doi: 10.1074/jbc.M117.793646. Epub 2017 Aug 15.

PMID:
28821618
10.

Detection and partial discrimination of atypical and classical bovine spongiform encephalopathies in cattle and primates using real-time quaking-induced conversion assay.

Levavasseur E, Biacabe AG, Comoy E, Culeux A, Grznarova K, Privat N, Simoneau S, Flan B, Sazdovitch V, Seilhean D, Baron T, Haïk S.

PLoS One. 2017 Feb 23;12(2):e0172428. doi: 10.1371/journal.pone.0172428. eCollection 2017.

11.

Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease.

Bougard D, Brandel JP, Bélondrade M, Béringue V, Segarra C, Fleury H, Laplanche JL, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-Wirth C, Knight R, Will R, Tiberghien P, Haïk S, Coste J.

Sci Transl Med. 2016 Dec 21;8(370):370ra182. doi: 10.1126/scitranslmed.aag1257.

PMID:
28003547
12.

Absence of Evidence for a Causal Link between Bovine Spongiform Encephalopathy Strain Variant L-BSE and Known Forms of Sporadic Creutzfeldt-Jakob Disease in Human PrP Transgenic Mice.

Jaumain E, Quadrio I, Herzog L, Reine F, Rezaei H, Andréoletti O, Laude H, Perret-Liaudet A, Haïk S, Béringue V.

J Virol. 2016 Nov 14;90(23):10867-10874. doi: 10.1128/JVI.01383-16. Print 2016 Dec 1.

13.

Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt-jakob disease: An international study.

McGuire LI, Poleggi A, Poggiolini I, Suardi S, Grznarova K, Shi S, de Vil B, Sarros S, Satoh K, Cheng K, Cramm M, Fairfoul G, Schmitz M, Zerr I, Cras P, Equestre M, Tagliavini F, Atarashi R, Knox D, Collins S, Haïk S, Parchi P, Pocchiari M, Green A.

Ann Neurol. 2016 Jul;80(1):160-5. doi: 10.1002/ana.24679. Epub 2016 Jun 1.

14.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

15.

[Spreading of protein misfolding: A new paradigm in neurology].

Hauw JJ, Haïk S, Duyckaerts C.

Rev Neurol (Paris). 2015 Dec;171(12):825-31. doi: 10.1016/j.neurol.2015.09.010. Epub 2015 Nov 11. Review. French.

PMID:
26573331
16.

[Is Parkinson's disease a prion disease?].

Brandel JP, Corbillé AG, Derkinderen P, Haïk S.

Rev Neurol (Paris). 2015 Dec;171(12):812-24. doi: 10.1016/j.neurol.2015.10.005. Epub 2015 Nov 10. Review. French.

PMID:
26563663
17.

History of Prions and transmission of protein misfolding.

Hauw JJ, Haik S, Brandel JP.

Bull Acad Natl Med. 2015 Jun;199(6):787-796.

PMID:
29901879
18.

A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.

Sanchez-Juan P, Bishop MT, Kovacs GG, Calero M, Aulchenko YS, Ladogana A, Boyd A, Lewis V, Ponto C, Calero O, Poleggi A, Carracedo Á, van der Lee SJ, Ströbel T, Rivadeneira F, Hofman A, Haïk S, Combarros O, Berciano J, Uitterlinden AG, Collins SJ, Budka H, Brandel JP, Laplanche JL, Pocchiari M, Zerr I, Knight RS, Will RG, van Duijn CM.

PLoS One. 2015 Apr 28;10(4):e0123654. doi: 10.1371/journal.pone.0123654. eCollection 2014.

19.

Molecular modeling of prion transmission to humans.

Levavasseur E, Privat N, Martin JC, Simoneau S, Baron T, Flan B, Torres JM, Haïk S.

Viruses. 2014 Oct 2;6(10):3766-77. doi: 10.3390/v6103766.

20.

Prions in the urine of patients with variant Creutzfeldt-Jakob disease.

Moda F, Gambetti P, Notari S, Concha-Marambio L, Catania M, Park KW, Maderna E, Suardi S, Haïk S, Brandel JP, Ironside J, Knight R, Tagliavini F, Soto C.

N Engl J Med. 2014 Aug 7;371(6):530-9. doi: 10.1056/NEJMoa1404401.

21.

Infectious prion diseases in humans: cannibalism, iatrogenicity and zoonoses.

Haïk S, Brandel JP.

Infect Genet Evol. 2014 Aug;26:303-12. doi: 10.1016/j.meegid.2014.06.010. Epub 2014 Jun 20. Review.

PMID:
24956437
22.

Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.

Halliez S, Reine F, Herzog L, Jaumain E, Haïk S, Rezaei H, Vilotte JL, Laude H, Béringue V.

J Virol. 2014 Aug;88(15):8678-86. doi: 10.1128/JVI.01118-14. Epub 2014 May 21.

23.

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.

Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, Cesaro P, Buffa C, Aucan C, Lucca U, Peckeu L, Suardi S, Tranchant C, Zerr I, Houillier C, Redaelli V, Vespignani H, Campanella A, Sellal F, Krasnianski A, Seilhean D, Heinemann U, Sedel F, Canovi M, Gobbi M, Di Fede G, Laplanche JL, Pocchiari M, Salmona M, Forloni G, Brandel JP, Tagliavini F.

Lancet Neurol. 2014 Feb;13(2):150-8. doi: 10.1016/S1474-4422(13)70307-7. Epub 2014 Jan 8.

PMID:
24411709
24.

Cycline efficacy on the propagation of human prions in primary cultured neurons is strain-specific.

Hannaoui S, Gougerot A, Privat N, Levavasseur E, Bizat N, Hauw JJ, Brandel JP, Haïk S.

J Infect Dis. 2014 Apr 1;209(7):1144-8. doi: 10.1093/infdis/jit623. Epub 2013 Nov 21.

PMID:
24265435
25.

PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, Ragagnin A, Mouillet-Richard S, Haik S, Bailly Y, Peyrin JM, Launay JM, Kellermann O, Schneider B.

Nat Med. 2013 Sep;19(9):1124-31. doi: 10.1038/nm.3302. Epub 2013 Aug 18.

PMID:
23955714
26.

The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.

Brandel JP, Peckeu L, Haïk S.

Transfus Clin Biol. 2013 Sep;20(4):395-7. doi: 10.1016/j.tracli.2013.02.029. Epub 2013 Apr 12. Review.

PMID:
23587616
27.

Glycoform-selective prion formation in sporadic and familial forms of prion disease.

Xiao X, Yuan J, Haïk S, Cali I, Zhan Y, Moudjou M, Li B, Laplanche JL, Laude H, Langeveld J, Gambetti P, Kitamoto T, Kong Q, Brandel JP, Cobb BA, Petersen RB, Zou WQ.

PLoS One. 2013;8(3):e58786. doi: 10.1371/journal.pone.0058786. Epub 2013 Mar 19.

28.

Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance.

Pradines E, Hernandez-Rapp J, Villa-Diaz A, Dakowski C, Ardila-Osorio H, Haik S, Schneider B, Launay JM, Kellermann O, Torres JM, Mouillet-Richard S.

Cell Death Dis. 2013 Jan 10;4:e456. doi: 10.1038/cddis.2012.195.

29.

Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Hannaoui S, Maatouk L, Privat N, Levavasseur E, Faucheux BA, Haïk S.

J Virol. 2013 Mar;87(5):2535-48. doi: 10.1128/JVI.03082-12. Epub 2012 Dec 19.

30.

Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries.

Diack AB, Ritchie D, Bishop M, Pinion V, Brandel JP, Haik S, Tagliavini F, Van Duijn C, Belay ED, Gambetti P, Schonberger LB, Piccardo P, Will RG, Manson JC.

Emerg Infect Dis. 2012 Oct;18(10):1574-9. doi: 10.3201/eid1810.120792.

31.

Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders.

Peoc'h K, Levavasseur E, Delmont E, De Simone A, Laffont-Proust I, Privat N, Chebaro Y, Chapuis C, Bedoucha P, Brandel JP, Laquerriere A, Kemeny JL, Hauw JJ, Borg M, Rezaei H, Derreumaux P, Laplanche JL, Haïk S.

Hum Mol Genet. 2012 Dec 15;21(26):5417-28. doi: 10.1093/hmg/dds377. Epub 2012 Sep 10. Erratum in: Hum Mol Genet. 2014 Apr 15;23(8):2234.

PMID:
22965875
32.

Rapidly progressive Alzheimer's disease: a multicenter update.

Schmidt C, Haïk S, Satoh K, Rábano A, Martinez-Martin P, Roeber S, Brandel JP, Calero-Lara M, de Pedro-Cuesta J, Laplanche JL, Hauw JJ, Kretzschmar H, Zerr I.

J Alzheimers Dis. 2012;30(4):751-6. doi: 10.3233/JAD-2012-120007.

PMID:
22460329
33.

Preclinical sporadic Creutzfeldt-Jakob disease in French blood donors: an epidemiologic model-based study.

Pillonel J, Brandel JP, Léon L, Salomon D, Haïk S, Capek I, Vaillant V, Coste J, Alpérovitch A.

Transfusion. 2012 Jun;52(6):1290-5. doi: 10.1111/j.1537-2995.2011.03459.x. Epub 2011 Dec 1.

PMID:
22128904
34.

Can mortality data provide reliable indicators for Creutzfeldt-Jakob disease surveillance? A study in France from 2000 to 2008.

Brandel JP, Welaratne A, Salomon D, Capek I, Vaillant V, Aouba A, Haïk S, Alpérovitch A.

Neuroepidemiology. 2011;37(3-4):188-92. doi: 10.1159/000332764. Epub 2011 Nov 2. Erratum in: Neuroepidemiology. 2012;38(3):193. Aouaba, Albertine [corrected to Aouba, Albertine].

PMID:
22057088
35.

Long-standing prion dementia manifesting as posterior cortical atrophy.

Depaz R, Haik S, Peoc'h K, Seilhean D, Grabli D, Vicart S, Sarazin M, DeToffol B, Remy C, Fallet-Bianco C, Laplanche JL, Fontaine B, Brandel JP.

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):289-92.

PMID:
21959360
36.

Biochemical and strain properties of CJD prions: complexity versus simplicity.

Haïk S, Brandel JP.

J Neurochem. 2011 Oct;119(2):251-61. doi: 10.1111/j.1471-4159.2011.07399.x. Epub 2011 Sep 20. Review.

37.

Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.

Faucheux BA, Morain E, Diouron V, Brandel JP, Salomon D, Sazdovitch V, Privat N, Laplanche JL, Hauw JJ, Haïk S.

Neuropathol Appl Neurobiol. 2011 Aug;37(5):500-12. doi: 10.1111/j.1365-2990.2011.01179.x.

PMID:
21450052
38.

Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus.

Lapergue B, Demeret S, Denys V, Laplanche JL, Galanaud D, Verny M, Sazdovitch V, Baulac M, Haïk S, Hauw JJ, Bolgert F, Brandel JP, Navarro V.

Neurology. 2010 Jun 15;74(24):1995-9. doi: 10.1212/WNL.0b013e3181e39703. Epub 2010 May 5.

PMID:
20445151
39.

Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases.

Galanaud D, Haik S, Linguraru MG, Ranjeva JP, Faucheux B, Kaphan E, Ayache N, Chiras J, Cozzone P, Dormont D, Brandel JP.

AJNR Am J Neuroradiol. 2010 Aug;31(7):1311-8. doi: 10.3174/ajnr.A2069. Epub 2010 Apr 29.

40.

Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans.

Bizat N, Peyrin JM, Haïk S, Cochois V, Beaudry P, Laplanche JL, Néri C.

J Neurosci. 2010 Apr 14;30(15):5394-403. doi: 10.1523/JNEUROSCI.5831-09.2010.

41.

Variant or sporadic Creutzfeldt-Jakob disease?

Brandel JP, Galanaud D, Freeman L, Laplanche JL, Haik S.

Lancet. 2010 Mar 13;375(9718):889; author reply 889-90. doi: 10.1016/S0140-6736(10)60378-9. No abstract available.

PMID:
20226976
42.

Creutzfeldt-Jakob disease in a patient treated by etanercept for rheumatoid arthritis (RA): just a coincidence?

Soubrier M, Haïk S, Hauw JJ, Corvol JC, Lyon-Caen O, Dougados M.

Joint Bone Spine. 2010 Mar;77(2):174-5. doi: 10.1016/j.jbspin.2009.05.016. Epub 2010 Jan 25.

PMID:
20097590
43.

[Doxycycline versus placebo trial in human prion diseases: a therapeutic challenge].

Brandel JP, Haïk S.

Rev Neurol (Paris). 2010 Mar;166(3):266-8. doi: 10.1016/j.neurol.2009.10.013. Epub 2009 Dec 21. French. No abstract available.

PMID:
20022619
44.

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P.

Brain. 2009 Oct;132(Pt 10):2659-68. doi: 10.1093/brain/awp191. Epub 2009 Sep 22. Erratum in: Brain. 2012 Apr;135(Pt 4):1335.

45.

Tau-positive grains are constant in centenarians' hippocampus.

Pham CT, de Silva R, Haïk S, Verny M, Sachet A, Forette B, Lees A, Hauw JJ, Duyckaerts C.

Neurobiol Aging. 2011 Jul;32(7):1296-303. doi: 10.1016/j.neurobiolaging.2009.07.009. Epub 2009 Aug 19.

PMID:
19695742
46.

Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.

Faucheux BA, Privat N, Brandel JP, Sazdovitch V, Laplanche JL, Maurage CA, Hauw JJ, Haïk S.

J Neuropathol Exp Neurol. 2009 Aug;68(8):892-901. doi: 10.1097/NEN.0b013e3181af7f23.

PMID:
19606064
47.

Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain.

Brandel JP, Heath CA, Head MW, Levavasseur E, Knight R, Laplanche JL, Langeveld JP, Ironside JW, Hauw JJ, Mackenzie J, Alpérovitch A, Will RG, Haïk S.

Ann Neurol. 2009 Mar;65(3):249-56. doi: 10.1002/ana.21583.

PMID:
19334063
48.

Wernicke encephalopathy and Creutzfeldt-Jakob disease.

Bertrand A, Brandel JP, Grignon Y, Sazdovitch V, Seilhean D, Faucheux B, Privat N, Brault JL, Vital A, Uro-Coste E, Pluot M, Chapon F, Maurage CA, Letournel F, Vespignani H, Place G, Degos CF, Peoc'h K, Haïk S, Hauw JJ.

J Neurol. 2009 Jun;256(6):904-9. doi: 10.1007/s00415-009-5038-1. Epub 2009 Mar 1.

PMID:
19252796
49.

Severe and rapidly evolving peripheral neuropathy revealing sporadic Creutzfeldt-Jakob disease.

Zéphir H, Stojkovic T, de Seze J, Maurage CA, Peoc'h K, Haïk S, Vermersch P.

J Neurol. 2009 Jan;256(1):134-6. doi: 10.1007/s00415-009-0037-9. Epub 2009 Feb 7. No abstract available.

PMID:
19219575
50.

Sleep disturbances in variant of Creutzfeldt-Jakob disease.

Limousin N, Corcia P, Guennoc AM, Lucas B, Sazdovitch V, Haïk S, De Toffol B, Praline J.

Sleep Med. 2009 Jun;10(6):690. doi: 10.1016/j.sleep.2008.08.003. Epub 2008 Dec 23. No abstract available.

PMID:
19109067

Supplemental Content

Support Center